Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

VPA-985 as a novel treatment option for hyponatremia in cirrhosis: clinical results

Nov. 15, 1999

Preclinical data reported at ASN support utility of OP-1 in treating renal disease

Nov. 12, 1999

Novel agents for renal diseases with benzimidazole structure

Nov. 11, 1999

NeXstar research leads to identification of new target for treating renal disease

Nov. 11, 1999

P-selectin blocker SKK-60037 may help prevent progressive renal injuries

Nov. 9, 1999

Selectin ligand antagonist TBC-1269 attenuates renal ischemic reperfusion injury in rats

Nov. 9, 1999

Vasopressin antagonist VPA-985: summary of clinical data presented at ASN

Nov. 9, 1999

Antifibrotic agent pirfenidone slows the progression of glomerulosclerosis

Nov. 8, 1999

News from ASN: PDGF tyrosine kinase is a target for intervention in renal diseases

Nov. 8, 1999

Agents for urinary incontinence, pollakiuria in early development at Fujisawa

Nov. 4, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...